A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Child Health and Human Development
Grant: HD0087314
NICHD NIH HHS
Grant: R01 HD087314
NIDDK NIH HHS
Grant: P30 DK048520
National Institutes of Health
Grant: 5R01HD087314-04
Reprometabolic Syndrome Mediates Subfertility in Obesity
FWCI
1.46
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals